CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe-/- mice

BMC Immunology

Volumn 11, Issue , 2010, Pages

  Kolbus, Daniel ^a   Ramos, Ornélia H ^a   Berg, Katarina E ^a   Persson, Josefin ^a   Wigren, Maria ^a   Björkbacka, Harry ^a   Fredrikson, Gunilla N ^a,b   Nilsson, Jan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CONCANAVALIN A; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; OXIDIZED LOW DENSITY LIPOPROTEIN; CD28 ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTICLE; CD28+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HYPERCHOLESTEROLEMIA; IMMUNE RESPONSE; LIPID DIET; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SHAM FEEDING; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; ATHEROGENIC DIET; ATHEROSCLEROSIS; BIOSYNTHESIS; CELL CULTURE; CHOLESTEROL INTAKE; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; SECRETION;

ANIMALS; ANTIGENS, CD28; ATHEROSCLEROSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHOLESTEROL, DIETARY; DIET, ATHEROGENIC; HYPERCHOLESTEROLEMIA; INTERFERON-GAMMA; INTERLEUKIN-10; LDL-RECEPTOR RELATED PROTEIN 1; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT;

EID: 78649598153     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-58     Document Type: Article

References (40)

1. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL. Innate and acquired immunity in atherogenesis. Nat Med 2002, 8:1218-26. 10.1038/nm1102-1218, 12411948.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-95. 10.1056/NEJMra043430, 15843671.
3. Nilsson J, Hansson GK. Autoimmunity in atherosclerosis: a protective response losing control?. J Intern Med 2008, 263:464-78. 10.1111/j.1365-2796.2008.01945.x, 18410590.
4. Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 2005, 115:3149-56. 10.1172/JCI25482, 1242192, 16211093.
5. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004, 101:10679-84. 10.1073/pnas.0403249101, 489994, 15249654.
6. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004, 10:416-21. 10.1038/nm1008, 15034566.
7. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997, 99:2752-61. 10.1172/JCI119465, 508122, 9169506.
8. Buono C, Binder CJ, Stavrakis G, Witztum JL, Glimcher LH, Lichtman AH. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci USA 2005, 102:1596-601. 10.1073/pnas.0409015102, 547865, 15665085.
9. Hauer AD, Uyttenhove C, de Vos P, Stroobant V, Renauld JC, van Berkel TJ, van Snick J, Kuiper J. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 2005, 112:1054-62. 10.1161/CIRCULATIONAHA.104.533463, 16103256.
10. George J, Shoenfeld Y, Gilburd B, Afek A, Shaish A, Harats D. Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ Res 2000, 86:1203-10.
11. Binder CJ, Hartvigsen K, Chang MK, Miller M, Broide D, Palinski W, Curtiss LK, Corr M, Witztum JL. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 2004, 114:427-37. 484976, 15286809.
12. Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F, Tedgui A, Groux H. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003, 108:1232-7. 10.1161/01.CIR.0000089083.61317.A1, 12912803.
13. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006, 12:178-80. 10.1038/nm1343, 16462800.
14. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002, 109:745-53. 150903, 11901183.
15. Palinski W, Witztum JL. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J Intern Med 2000, 247:371-80. 10.1046/j.1365-2796.2000.00656.x, 10762454.
16. Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007, 116:1832-44. 10.1161/CIRCULATIONAHA.106.676890, 17938300.
17. Hulthe J. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies. Clin Chim Acta 2004, 348:1-8. 10.1016/j.cccn.2004.05.021, 15369729.
18. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995, 92:3893-7. 10.1073/pnas.92.9.3893, 42068, 7732003.
19. Frostegård J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T cell activation by oxidized low density lipoprotein. Arteriosclerosis and Thrombosis 1992, 12:461-467.
20. Zhou X, Robertson AK, Hjerpe C, Hansson GK. Adoptive Transfer of CD4+ T Cells Reactive to Modified Low-Density Lipoprotein Aggravates Atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26(4):864-70. 10.1161/01.ATV.0000206122.61591.ff, 16456097.
21. Fredrikson GN, Soderberg I, Lindholm M, Dimayuga P, Chyu KY, Shah PK, Nilsson J. Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences. Arterioscler Thromb Vasc Biol 2003, 23:879-84. 10.1161/01.ATV.0000067937.93716.DB, 12649092.
22. Chyu KY, Zhao X, Reyes OS, Babbidge SM, Dimayuga PC, Yano J, Cercek B, Fredrikson GN, Nilsson J, Shah PK. Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice. Biochem Biophys Res Commun 2005, 338:1982-9. 10.1016/j.bbrc.2005.10.141, 16288717.
23. Fredrikson GN, Bjorkbacka H, Soderberg I, Ljungcrantz I, Nilsson J. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies. J Intern Med 2008, 264:563-70. 10.1111/j.1365-2796.2008.01995.x, 18783480.
24. Nilsson J, Hansson GK, Shah PK. Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler Thromb Vasc Biol 2005, 25:18-28. 10.1161/01.ATV.0000174796.81443.3f, 15514204.
25. Palinski W, Horkko S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996, 98:800-14. 10.1172/JCI118853, 507491, 8698873.
26. Fredrikson GN, Berglund G, Alm R, Nilsson JA, Shah PK, Nilsson J. Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide. J Lipid Res 2006, 47:2049-54. 10.1194/jlr.M600217-JLR200, 16809787.
27. Zhou X, Paulsson G, Stemme S, Hansson GK. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 1998, 101:1717-25. 10.1172/JCI1216, 508754, 9541503.
28. Habets KL, van Puijvelde GH, van Duivenvoorde LM, van Wanrooij EJ, de Vos P, Tervaert JW, van Berkel TJ, Toes RE, Kuiper J. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. Cardiovasc Res 85:622-30. 10.1093/cvr/cvp338, 19819882.
29. Hjerpe C, Johansson D, Hermansson A, Hansson GK, Zhou X. Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice. Atherosclerosis 209:436-41. 10.1016/j.atherosclerosis.2009.10.003, 19897195.
30. Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hansson GK. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001, 21:108-14. 10.1161/hq0901.096582, 11145941.
31. Gautier EL, Huby T, Saint-Charles F, Ouzilleau B, Pirault J, Deswaerte V, Ginhoux F, Miller ER, Witztum JL, Chapman MJ, et al. Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis. Circulation 2009, 119:2367-75. 10.1161/CIRCULATIONAHA.108.807537, 19380622.
32. Packard RR, Maganto-Garcia E, Gotsman I, Tabas I, Libby P, Lichtman AH. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circ Res 2008, 103:965-73. 10.1161/CIRCRESAHA.108.185793, 2668806, 18832748.
33. Zhou X, Stemme S, Hansson GK. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol 1996, 149:359-66. 1865326, 8701976.
34. Gewaltig J, Kummer M, Koella C, Cathomas G, Biedermann BC. Requirements for CD8 T-cell migration into the human arterial wall. Hum Pathol 2008, 39:1756-62. 10.1016/j.humpath.2008.04.018, 18706675.
35. Ludewig B, Freigang S, Jaggi M, Kurrer MO, Pei YC, Vlk L, Odermatt B, Zinkernagel RM, Hengartner H. Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc Natl Acad Sci USA 2000, 97:12752-7. 10.1073/pnas.220427097, 18836, 11050173.
36. Conen KL, Jeanneret C, Hecker B, Cathomas G, Biedermann BC. Acute occlusive large vessel disease leading to fatal stroke in a patient with systemic lupus erythematosus: arteritis or atherosclerosis?. Arthritis Rheum 2006, 54:908-13. 10.1002/art.21656, 16508973.
37. Elhage R, Gourdy P, Brouchet L, Jawien J, Fouque MJ, Fievet C, Huc X, Barreira Y, Couloumiers JC, Arnal JF, et al. Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol 2004, 165:2013-8. 1618721, 15579444.
38. Glass CK, Witztum JL. Atherosclerosis: The Road Ahead. Cell 2001, 104:503-516. 10.1016/S0092-8674(01)00238-0, 11239408.
39. Bentzon JF, Falk E. Atherosclerotic lesions in mouse and man: is it the same disease?. Curr Opin Lipidol 2010, 21(5):434-40. 10.1097/MOL.0b013e32833ded6a, 20683327.
40. Ait-Oufella H, Kinugawa K, Zoll J, Simon T, Boddaert J, Heeneman S, Blanc-Brude O, Barateau V, Potteaux S, Merval R, et al. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 2007, 115:2168-77. 10.1161/CIRCULATIONAHA.106.662080, 17420351.